← Leaderboards
Margaret A Schwarz
Children'S Hospital Los Angeles
$6,693,034
Attributed
$6,693,034
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $770.6K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,693,034 · 8
By mechanism
R01$4,816,812 · 3
R56$715,161 · 1
R21$629,063 · 2
K02$418,770 · 1
R29$113,228 · 1
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Los Angeles
Same institution · by research overlap
- Walter E Laug$643,067
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungAngiogenesisLaboratory MouseVascular Endothelial Growth FactorsCell ProliferationWestern BlottingsCell CycleMonocyteIn Situ HybridizationPolymerase Chain ReactionImmunocytochemistryAngiogenesis FactorCell Growth RegulationAngiogenesis InhibitorsFlow CytometryGene ExpressionAlveolarEndothelial Monocyte-Activating Polypeptide IiMediator Of Activation ProteinGrowthPolypeptideMediatingEndothelial CellsBlood Capillaries
Grant awards (26)
Epigenetic regulation of pulmonary smooth muscle cell remodeling in Pulmonary Hypertension$715,161
R56 · FY2023 · HL · contact PI
Decoding Mediators in Lung Development$196,875
R21 · FY2019 · HD · contact PI
Decoding Mediators in Lung Development$236,250
R21 · FY2018 · HD · contact PI
A New System to Modulate Phosphatidylserine to Investigate Filovirus Budding$195,938
R21 · FY2017 · AI · contact PI
EMAP II: Pulmonary Vascular Mediator$429,906
R01 · FY2015 · HL · contact PI
EMAP II: Pulmonary Vascular Mediator$427,722
R01 · FY2014 · HL · contact PI
EMAP II: Pulmonary Vascular Mediator$415,503
R01 · FY2013 · HL · contact PI
EMAP II: Pulmonary Vascular Mediator$502,345
R01 · FY2012 · HL · contact PI
EMAP II Regulation of Pulmonary Cell Proliferation$276,659
R01 · FY2007 · HL · contact PI
EMAP II Regulation of Pulmonary Cell Proliferation$91,946
R01 · FY2007 · HL · contact PI
EMAP II Regulation of Pulmonary Cell Proliferation$379,614
R01 · FY2006 · HL · contact PI
Vasculature is a determinant of epithelial morphogenesis$230,121
R01 · FY2006 · HL · contact PI
Vasculature is a determinant of epithelial morphogenesis$149,493
R01 · FY2006 · HL · contact PI
Vasculature is a determinant of epithelial morphogenesis$388,750
R01 · FY2005 · HL
EMAP II Regulation of Pulmonary Cell Proliferation$381,813
R01 · FY2005 · HL
Vasculature is a determinant of epithelial morphogenesis$388,750
R01 · FY2004 · HL
EMAP II Regulation of Pulmonary Cell Proliferation$370,990
R01 · FY2004 · HL
Vasculature is a determinant of epithelial morphogenesis$383,200
R01 · FY2003 · HL
ROLE OF A NEGATIVE MODULATOR OF NEOVASCULARIZATION$102,870
K02 · FY2003 · HL
ROLE OF A NEGATIVE MODULATOR OF NEOVASCULARIZATION$102,870
K02 · FY2002 · HL
ROLE OF A NEGATIVE MODULATOR OF NEOVASCULARIZATION$86,817
K02 · FY2001 · HL
MODULATORS OF NEOVASCULARIZATION IN THE DEVELOPING LUNG$47,471
R29 · FY2001 · HL
ROLE OF A NEGATIVE MODULATOR OF NEOVASCULARIZATION$19,698
K02 · FY2001 · HL
MODULATORS OF NEOVASCULARIZATION IN THE DEVELOPING LUNG$9,143
R29 · FY2001 · HL
ROLE OF A NEGATIVE MODULATOR OF NEOVASCULARIZATION$106,515
K02 · FY2000 · HL
MODULATORS OF NEOVASCULARIZATION IN THE DEVELOPING LUNG$56,614
R29 · FY2000 · HL